微创青光眼手术患者的健康相关生活质量评估工具
本研究开发了青光眼结局调查问卷(GOS),用于评估青光眼及治疗(包括微创青光眼手术)对患者的影响。184名成人完成基线调查,124名完成术后3个月调查,106名完成1个月重测信度调查。GOS各量表内部一致性信度为0.75至0.93,重测组内相关系数为0.83至0.92;视力改善与功能限制、视觉相关症状及心理社会关注的改善显著相关。
要点
- GOS包含功能限制(27项)、视觉相关症状(7项)、心理社会问题(7项)及微创青光眼手术满意度(1项)四个量表。
- GOS各量表内部一致性信度为0.75至0.93,1个月重测组内相关系数为0.83至0.92。
- 视力改善与GOS功能限制(r=0.18,P=.0485)、视觉相关症状(r=0.19,P=.0386)及心理社会关注(r=0.18,P=.0503)的改善显著相关。
核心结论
- 本研究支持将GOS用于微创青光眼手术等眼科手术的评估。
- 需要在不同患者亚组和临床环境中进一步评估GOS。
研究设计与样本
- 观察性研究,在同期白内障手术及美国食品药品监督管理局批准的植入式微创青光眼手术装置手术前后进行。
- 184名成人完成基线调查,124名完成术后3个月调查,106名完成1个月重测信度调查。
- 年龄范围37至89岁(平均年龄72岁),大多数为女性(57%)、非西班牙裔白人(81%),具有大学学位(56%)。
主要发现
- GOS各量表内部一致性信度估计为0.75至0.93,1个月重测组内相关系数为0.83至0.92。
- 各量表间的积矩相关系数为0.56至0.60。
- 研究眼视力从基线至3个月随访的改善与GOS功能限制(r=0.18,P=.0485)、视觉相关症状(r=0.19,P=.0386)及心理社会关注(r=0.18,P=.0503)的改善显著相关。
- 治疗应答率从视觉相关症状的17%到功能限制的48%。
局限性
- 需要在不同患者亚组和临床环境中进一步评估GOS。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To develop a patient-reported outcome measure to assess the impact of glaucoma and treatment, including minimally invasive glaucoma surgery (MIGS). DESIGN: Observational study before and after concomitant cataract and Food and Drug Administration-approved implantable MIGS device surgery. SETTING: Survey administration was on a computer, iPad, or similar device. PATIENT POPULATION: 184 adults completed the baseline survey, 124 a survey 3 months after surgery, and 106 the 1-month test-retest reliability survey. The age range was 37 to 89 (average age = 72). Most were female (57%), non-Hispanic White (81%), and had a college degree (56%). MAIN OUTCOME MEASURES: The Glaucoma Outcomes Survey (GOS) assesses functional limitations (27 items), vision-related symptoms (7 items), psychosocial issues (7 items), and satisfaction with microinvasive glaucoma surgery (1 item). These multiple-item scales were scored on a 0 to 100 range, with a higher score indicating worse health. RESULTS: Internal consistency reliability estimates ranged from 0.75 to 0.93, and 1-month test-retest intraclass correlations ranged from 0.83 to 0.92 for the GOS scales. Product-moment correlations among the scales ranged from 0.56 to 0.60. Improvement in visual acuity in the study eye from baseline to the 3-month follow-up was significantly related to improvements in GOS functional limitations (r = 0.18, P = .0485), vision-related symptoms (r = 0.19, P = .0386), and psychosocial concerns (r = 0.18, P = .0503). Responders to treatment ranged from 17% for vision-related symptoms to 48% for functional limitations. CONCLUSIONS: This study supports using the GOS for ophthalmic procedures such as MIGS. Further evaluation of the GOS in different patient subgroups and clinical settings is needed.
引用
- Hays RD, Tarver ME, Eydelman M, et al. A Health-Related Quality of Life Measure for Patients Who Undergo Minimally Invasive Glaucoma Surgery. Am J Ophthalmol. 2024. PMID: 38880374. doi:10.1016/j.ajo.2024.05.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。